Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hoth Therapeutics Inc (NQ: HOTH )

0.8600 +0.0100 (+1.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... 
Via Benzinga
Nasdaq Falls 100 Points; Dermata Therapeutics Shares Surge
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Friday. 
Via Benzinga
EF Hutton Maintains Buy Rating for Hoth Therapeutics: Here's What You Need To Know
Via Benzinga
FDA Signs Off Hoth Therapeutics' Trial Application For HT-001 For Skin Cancers
Via Benzinga
Why Hoth Therapeutics Shares Are Nosediving
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading lower by 21.22% to $8.44 Friday morning after the company announced a $10 million private placement priced at-the-market under Nasdaq rules. 
Via Benzinga
US Stocks Open Lower; Dow Drops 250 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. 
Via Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday. 
Via Benzinga
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END 
Via FinancialNewsMedia
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to... 
Via Benzinga
Tesla, Apple, Ford, Southwest Airlines, Hoth Therapeutics: Why These Five Stocks Are Drawing Investors' Attention Today?
Major Wall Street indices closed over 1% higher on Thursday after the much-awaited year-end rally materialized in the form of dip-buying. The Nasdaq Composite closed 2.59% higher while the S&P 500 rose... 
Via Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information.... 
Via Benzinga
Dow Rises Over 1%; Cal-Maine Foods Shares Plummet
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 250 points on Thursday. 
Via Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Jumps Over 250 Points; Crude Oil Down 1%
U.S. stocks traded higher midway through trading, with the Dow Jones climbing around 400 points on Thursday. 
Via Benzinga
Dow, Nasdaq Up Triple Digits In Latest Last-Ditch Rally
Stocks are attempting a last-minute rally before the year comes to a close, as investors react to higher-than-expected jobless claims data. 
Via Talk Markets
Dow Surges 250 Points; Jobless Claims Rise To 225,000
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... 
Via Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small... 
Via Benzinga
Why Is Hoth Therapeutics (HOTH) Stock Up 24% Today?
Hoth Therapeutics (HOTH) stock is rising higher on Monday with heavy trading and positive results from a Phase 1 clinical trial of BioLexa. 
Via InvestorPlace
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its... 
Via Benzinga
Nasdaq Down Over 100 Points; Chicago PMI Drops Further
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. 
Via Benzinga
Hoth Therapeutics (NASDAQ: HOTH) Releases BioLexa Phase 1B Trial Results Showing Positive Results in Treating Mild to Moderate Atopic Dermatitis
Hoth Therapeutics, Inc. (NASDAQ: HOTH) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
Via Spotlight Growth
Hoth Therapeutics' Atopic Dermatitis Candidate Shows Improvement In Severity, Shares Jump
Hoth Therapeutics Inc (NASDAQ: HOTH) announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis. 
Via Benzinga
What's Going On With Hoth Therapeutics Stock?
Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher Monday after the company announced positive BioLexa Phase 1b clinical trial results. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 53 companies reached new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.